4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-007484
Chief Medical Officer sold 17,500 shares at an average $18.72 ($327,589)
- Chief Medical Officer acquired 17,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2019-02-01 | Option exercise | +5,775 | $5.28 | $30,492 | 5,775 | D |
| Ho Carole Chief Medical Officer | 2019-02-01 | Sale | −5,775 | $18.64 | $107,646 | 0 | D |
| Ho Carole Chief Medical Officer | 2019-02-04 | Option exercise | +730 | $5.28 | $3,854 | 730 | D |
| Ho Carole Chief Medical Officer | 2019-02-04 | Option exercise | +3,139 | $5.28 | $16,574 | 3,869 | D |
| Ho Carole Chief Medical Officer | 2019-02-04 | Sale | −3,100 | $18.49 | $57,319 | 769 | D |
| Ho Carole Chief Medical Officer | 2019-02-04 | Sale | −769 | $19.11 | $14,696 | 0 | D |
| Ho Carole Chief Medical Officer | 2019-02-05 | Option exercise | +7,856 | $5.28 | $41,480 | 7,856 | D |
| Ho Carole Chief Medical Officer | 2019-02-05 | Sale | −7,856 | $18.83 | $147,928 | 0 | D |
| Derivatives | |||||||
| Ho Carole Chief Medical Officer | 2019-02-01 | Option exercise · Stock Option (right to buy) | −5,775 | 96,610 | D | ||
| Ho Carole Chief Medical Officer | 2019-02-04 | Option exercise · Stock Option (right to buy) | −730 | 95,880 | D | ||
| Ho Carole Chief Medical Officer | 2019-02-04 | Option exercise · Stock Option (right to buy) | −3,139 | 137,486 | D | ||
| Ho Carole Chief Medical Officer | 2019-02-05 | Option exercise · Stock Option (right to buy) | −7,856 | 129,630 | D | ||
| Open-market sales · 17,500 sh · avg $18.72 · $327,589 | |||||||
Loading xslF345X03/doc4.xml…